Naseem Zojwalla - Dec 6, 2023 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Dec 6, 2023
Transactions value $
$91,962
Form type
4
Date filed
12/7/2023, 08:30 PM
Previous filing
Nov 22, 2023
Next filing
Dec 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Options Exercise $92K +13.1K +42.72% $7.02 43.8K Dec 6, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -13.1K -5.24% $0.00 237K Dec 6, 2023 Common Stock 13.1K $7.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.